FAT10 has negative effects on p53; downregulating p53 may have a negative downstream effect on BCL-2, leading to increased liver cell death, which suggests possible intervention of FAT10 on NAFLD development. Here, BCL2 is linked to metabolic dysfunction-associated steatotic liver disease.